Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
76.5K
-
Shares change
-
-2.04K
-
Total reported value, excl. options
-
$222K
-
Value change
-
-$6.35K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$2.97
Significant Holders of Arcadia Biosciences, Inc. - COM (RKDA) as of Q1 2025
15 filings reported holding RKDA - Arcadia Biosciences, Inc. - COM as of Q1 2025.
Arcadia Biosciences, Inc. - COM (RKDA) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.5K shares
.
Largest 10 shareholders include Mariner, LLC (27.5K shares), VANGUARD GROUP INC (14K shares), GEODE CAPITAL MANAGEMENT, LLC (12.8K shares), STATE STREET CORP (12.1K shares), UBS Group AG (8.56K shares), MORGAN STANLEY (608 shares), Tower Research Capital LLC (TRC) (437 shares), ATTICUS WEALTH MANAGEMENT, LLC (272 shares), SBI Securities Co., Ltd. (120 shares), and GROUP ONE TRADING LLC (18 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.